BUTTS STEVE
Directeur Général chez Arrivo Management LLC
Profil
Steve has over 20 years of experience in the healthcare industry as an executive as well as various commercial roles including brand leadership, new product planning, business development and sales management.
Prior to founding Arrivo, Steve was the co-founder, President and COO of Aerial BioPharma LLC (“Aerial”), a drug development company that sold its lead drug for narcolepsy to Jazz Pharmaceuticals in 2014.
Prior to Aerial, Steve was co-founder and Executive Vice President of Neuronex Inc. (“Neuronex”), a successful drug development company focused on developing treatments for patients with certain seizure disorders.
Acorda Therapeutics acquired Neuronex in December 2012.
Additionally, he was an original member of the executive team at Addrenex Pharmaceuticals (“Addrenex”), a specialty pharmaceutical development company.
Steve served as Vice President of Commercial Operations and played a key role in the company’s sale to Shionogi Pharma in 2009.
He has also served as Vice President of Sales & Marketing at BioBehavioral Diagnostics Company, as well as assignments at Eli Lilly and Company and Braintree Laboratories.
Postes actifs de BUTTS STEVE
| Sociétés | Poste | Début |
|---|---|---|
Solas Bioventures (mayfield) LLC
 Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Consultant / Advisor | - |
Arrivo Management LLC
 Arrivo Management LLC BiotechnologyHealth Technology Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC. | Directeur Général | 01/09/2015 |
Knopp Biosciences LLC
 Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 01/07/2020 |
QuatroBio LLC
 QuatroBio LLC Miscellaneous Commercial ServicesCommercial Services QuatroBio LLC engages in drug development services. The company was founded by Moise A. Khayrallah on September 4, 2014 and is headquartered in Morrisville, NC. | Directeur Général | 01/07/2015 |
EnviCor Enterprises LLC
 EnviCor Enterprises LLC Industrial MachineryProducer Manufacturing EnviCor Enterprises LLC designs and manufactures plastic molders. It offers custom molders for the manufacture of paddle boards, barrels, plastic containers, septic equipment and water tanks. The company was founded by G. Steve Arnold in 2006 and is headquartered in Smithfield, NC. | Président | 01/01/2007 |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Directeur/Membre du Conseil | - |
Anciens postes connus de BUTTS STEVE
| Sociétés | Poste | Fin |
|---|---|---|
Aerial BioPharma LLC
 Aerial BioPharma LLC Pharmaceuticals: MajorHealth Technology Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC. | Fondateur | 01/01/2015 |
Neuronex, Inc.
 Neuronex, Inc. Pharmaceuticals: MajorHealth Technology Neuronex, Inc. developed drugs to treat central nervous system diseases and disorders. The company was founded by Stephen Butts and Moise Khayrallah in 2010 and was headquartered in Morrisville, NC. | Fondateur | 01/12/2012 |
Addrenex Pharmaceuticals, Inc.
 Addrenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Addrenex Pharmaceuticals, Inc. manufactures pharmaceuticals and drugs. Its focus on adrenergic regulation is indicated in therapeutic categories such as hypertension, ADHD, migraine and post-menopausal symptoms. The company was founded by H. Joseph Horacek and Moise A. Khayrallah in June 2006 and is headquartered in Durham, NC. | Private Equity Investor | 01/11/2009 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de BUTTS STEVE
| Kenan-Flagler Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
BioBehavioral Diagnostics Co.
 BioBehavioral Diagnostics Co. Medical SpecialtiesHealth Technology BioBehavioral Diagnostics Co. manufactures and markets attention-deficit hyperactivity disorder systems. It develops and markets a proprietary platform technology to objectively measure specific behaviors that correlate with brain function and deficits in inhibitory control. The firm's product Quotient ADHD System measures impulsivity, hyperactivity and inattention as an aid in the assessment of ADHD and this system includes a data acquisition unit, a proprietary normative database, analytics and reports. The company was founded by Eric B. Gordon in 2006 and is headquartered in Westford, MA. | Health Technology |
Addrenex Pharmaceuticals, Inc.
Addrenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Addrenex Pharmaceuticals, Inc. manufactures pharmaceuticals and drugs. Its focus on adrenergic regulation is indicated in therapeutic categories such as hypertension, ADHD, migraine and post-menopausal symptoms. The company was founded by H. Joseph Horacek and Moise A. Khayrallah in June 2006 and is headquartered in Durham, NC. | Health Technology |
Knopp Biosciences LLC
Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Neuronex, Inc.
Neuronex, Inc. Pharmaceuticals: MajorHealth Technology Neuronex, Inc. developed drugs to treat central nervous system diseases and disorders. The company was founded by Stephen Butts and Moise Khayrallah in 2010 and was headquartered in Morrisville, NC. | Health Technology |
Aerial BioPharma LLC
Aerial BioPharma LLC Pharmaceuticals: MajorHealth Technology Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC. | Health Technology |
EnviCor Enterprises LLC
EnviCor Enterprises LLC Industrial MachineryProducer Manufacturing EnviCor Enterprises LLC designs and manufactures plastic molders. It offers custom molders for the manufacture of paddle boards, barrels, plastic containers, septic equipment and water tanks. The company was founded by G. Steve Arnold in 2006 and is headquartered in Smithfield, NC. | Producer Manufacturing |
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Finance |
Arrivo Management LLC
Arrivo Management LLC BiotechnologyHealth Technology Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC. | Health Technology |
QuatroBio LLC
QuatroBio LLC Miscellaneous Commercial ServicesCommercial Services QuatroBio LLC engages in drug development services. The company was founded by Moise A. Khayrallah on September 4, 2014 and is headquartered in Morrisville, NC. | Commercial Services |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Health Technology |